Related Experiment Video
Updated: Aug 25, 2025
11:19
Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
15.1K
TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis
Qian-Zhi Chen1, Yan Chen2, Xia Li3
1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Current Medical Science
|October 16, 2022
Summary
Tribbles pseudokinase 3 (TRIB3) promotes colon cancer angiogenesis by activating the STAT3/VEGFA pathway. Targeting TRIB3 offers a new therapeutic strategy for TRIB3-overexpressed cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Vascular endothelial growth factor A (VEGFA) drives angiogenesis, crucial for tumor growth and metastasis.
- Identifying novel targets regulating VEGFA-mediated angiogenesis is vital for effective cancer treatment.
Purpose of the Study:
- To investigate the role of the tribbles pseudokinase 3 (TRIB3)/signal transducer and activator of transcription 3 (STAT3)/VEGFA signaling axis in colon cancer angiogenesis.
- To explore TRIB3 as a potential therapeutic target for colon cancer.
Main Methods:
- Database and tissue microarray analysis to assess TRIB3 expression in colon cancer.
- In vitro assays (CCK8, migration, tube formation) to evaluate TRIB3's effect on endothelial cells.
- qPCR, Western blotting, immunoprecipitation, and chromatin immunoprecipitation to elucidate the TRIB3/STAT3/VEGFA regulatory mechanism.
- In vivo animal experiments to confirm findings.
Main Results:
- TRIB3 expression is elevated in colon cancer tissues and correlates with poor prognosis.
- TRIB3 silencing inhibits, while overexpression promotes, colon cancer angiogenesis in vitro and in vivo.
- TRIB3 physically interacts with STAT3, enhancing its transcriptional activity.
- TRIB3 promotes angiogenesis by increasing VEGFA expression via the STAT3 pathway.
Conclusions:
- The TRIB3/STAT3/VEGFA axis plays a significant role in colon cancer angiogenesis.
- TRIB3 represents a potential therapeutic target for cancers with TRIB3 overexpression.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:20The JAK-STAT Signaling Pathway
9.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:10Mechanism of Angiogenesis
5.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K